Valbiotis

Valbiotis est membre de Lyonbiopôle

General information

12F, Rue Paul Vatine

17180 Périgny

Incorporated in: 2018/09/10

Number of employees: 44


More information

 

Main activity

Valbiotis is a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach, aiming to revolutionize healthcare by developing a new class of health nutrition products designed to reduce the risk of major metabolic diseases, relying ona multi-target strategyenabled by the use of plant-basedterrestrial and marineresources.Its products are intended to be licensed to players in the health sector.Created at the beginning of 2014 in La Rochelle, the Company has forged numerous partnerships with leading academic centers. The Company has established three sites in France–Périgny, La Rochelle (17) and Riom (63)–and a subsidiary in Quebec City (Canada).Valbiotis is a member of the "BPI Excellence" network and has been recognized as an "Innovative Company" by the BPI label. Valbiotis hasalso been awarded "Young Innovative Company" status and has received major financial support from the European Union for its research programs via the European Regional Development Fund (ERDF). Valbiotis is a PEA-SME eligible company.


Funding

Stock exchange listing: Listed on the Stock Exchange on Euronext Growth since 2017

Segmentation
Activities
Products / Services / Technologies

Strategic area of application
Human Medicine


Application market
Metabolic Diseases


Activities
Nutrition & Health products